Cargando…
Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
PURPOSE: Axillary lymph node status is the strongest prognostic indicator of survival for women with breast cancer. The purpose of this study was to evaluate whether sentinel lymph node biopsy (SLNB) is required in patients with an initial diagnosis of ductal carcinoma in situ (DCIS). METHODS: A ret...
Autores principales: | Son, Bok Kyoung, Bong, Jin Gu, Park, Sung Hwan, Jeong, Young Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268927/ https://www.ncbi.nlm.nih.gov/pubmed/22323917 http://dx.doi.org/10.4048/jbc.2011.14.4.301 |
Ejemplares similares
-
Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Hung, Peiyin, et al.
Publicado: (2019) -
De-escalation of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ
por: Abdulla, Hussain A, et al.
Publicado: (2023) -
Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis
por: Shin, Young Duck, et al.
Publicado: (2021) -
Sentinel Node Biopsy in Ductal Carcinoma in Situ: Is it Justifiable?
por: Al-Shurbasi, Nour, et al.
Publicado: (2021) -
Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ
por: Killelea, Brigid K., et al.
Publicado: (2018)